PURB

PURB (Purβ) is a sequence-specific single-stranded DNA- and RNA-binding protein that functions as a transcriptional repressor and post-transcriptional regulator controlling cell identity and lineage-specific gene programs (PMID:9334258, PMID:23724822). It was first defined as a component of vascular actin single-stranded DNA-binding factor 2 that binds the purine-rich strand of the MCAT enhancer of the smooth muscle alpha-actin (ACTA2) gene to repress its transcription (PMID:9334258), and its minimal single-stranded DNA/RNA-binding domain maps to a core central region (residues ~37–263) whose repressor activity additionally requires a C-terminal domain (PMID:12874279). Purβ forms a reversible, asymmetric homodimer in the absence of nucleic acid (PMID:17121857) and uses three unequal single-stranded DNA-binding modules to engage two G/A-rich sites in the ACTA2 sense-strand enhancer in a sequential, cooperative, 2:1 protein:DNA arrangement (PMID:19496623, PMID:23724822). At the ACTA2 promoter Purβ acts as a suppressor of myofibroblast differentiation: its activity is potentiated by MSY1 and antagonized by SRF, and TGFβ1 signaling drives dynamic exchange of Pur proteins within SRF- and pSmad3/MRTF-A–containing complexes, with loss of Purβ derepressing ACTA2 and promoting a myofibroblast-like phenotype (PMID:12874279, PMID:23724822, PMID:24446247). Beyond ACTA2, Purβ enforces long-term silencing of lineage-specific genes by forming a Cbx1/Sp3 complex that positions nucleosomes and couples to PRC2-mediated H3K27me3 deposition (PMID:35605661), and it serves as an acetylation-dependent corepressor for p53 that selectively represses the p21 promoter through sequence-specific binding to the lncRNA HOTAIR and recruitment of EZH2 (PMID:40563010). Purβ also acts as a positive transcriptional regulator in metabolic contexts, directly binding the Adcy6 promoter to drive hepatic glucose production (PMID:31918924). In addition to its DNA roles, Purβ binds the smooth muscle alpha-actin mRNA, participates in mRNP formation, and suppresses translation (PMID:10608902).

1. 1997 Medium

   Established PURB's founding identity by showing it binds the purine-rich strand of a smooth muscle gene enhancer to repress transcription, defining it as a single-stranded DNA-binding repressor.

   Evidence Expression library screening, band shift, and Southwestern blotting with recombinant and cellular proteins on the ACTA2 MCAT enhancer

   PMID:9334258

   Open questions at the time

   • Did not map the binding domain
   • Repression mechanism beyond DNA binding undefined
2. 1999 High

   Extended PURB beyond DNA to show it binds the cognate mRNA, joins mRNP particles, and suppresses translation, revealing a dual nucleic-acid regulatory role.

   Evidence Cell-free RNA binding, translational reporter assays in fibroblasts, and deletion mutagenesis to map functional determinants

   PMID:10608902

   Open questions at the time

   • Physiological scope of translational repression not established
   • Which endogenous mRNAs are regulated unknown
3. 2003 High

   Mapped the minimal ssDNA/RNA-binding domain and showed repressor activity requires both this region and a C-terminal domain, while MSY1 and SRF oppositely modulate Purβ.

   Evidence Deletion-mutant Southwestern/Northwestern blotting, quantitative binding, and promoter-reporter assays in A7r5 cells

   PMID:12874279

   Open questions at the time

   • Structural basis of cofactor modulation unresolved
   • Purα vs Purβ functional distinction not mechanistically explained
4. 2006 High

   Defined the oligomeric state by demonstrating Purβ self-associates into a reversible, highly asymmetric homodimer, providing the structural unit for DNA engagement.

   Evidence Analytical ultracentrifugation and light scattering on purified recombinant protein

   PMID:17121857

   Open questions at the time

   • High-resolution structure absent
   • Link between dimer asymmetry and DNA binding not directly tested here
5. 2009 High

   Resolved the DNA-binding mechanism, showing cooperative, sequential occupancy of two G/A-rich enhancer sites to form a stable 2:1 complex.

   Evidence Quantitative binding assays, DNase I footprint titrations, and statistical-mechanical modeling with purified components

   PMID:19496623

   Open questions at the time

   • In vivo relevance of measured cooperativity untested
   • Contribution of dimerization to cooperativity not isolated
6. 2010 Medium

   Identified a protease-resistant core domain that retains self-association and higher-affinity purine-rich DNA binding, refining the functional architecture.

   Evidence Limited proteolysis, mass spectrometry, CD, and comparative DNA-binding assays

   PMID:20728429

   Open questions at the time

   • Single-study biochemical mapping without structure
   • Role of removed regions in cells unknown
7. 2013 High

   Tied biochemistry to phenotype by demonstrating Purβ knockdown derepresses ACTA2 and drives a migratory, myofibroblast-like state, establishing Purβ as a suppressor of myofibroblast differentiation.

   Evidence Stable shRNA knockdown in MEFs with morphology, migration, promoter-reporter, and domain-mapping assays

   PMID:23724822

   Open questions at the time

   • In vivo fibrosis relevance not tested
   • Full set of derepressed targets undefined
8. 2014 Medium

   Clarified the dynamics of repression by showing TGFβ1 remodels SRF/Pur and pSmad3/MRTF-A complexes with sequential Purβ-then-Purα exchange during myofibroblast maturation.

   Evidence Gel shift with nuclear extracts and co-immunoprecipitation in TGFβ1-stimulated pulmonary myofibroblasts

   PMID:24446247

   Open questions at the time

   • Signal that triggers Pur isoform exchange unknown
   • Co-IP without reciprocal/structural validation of the transient complex
9. 2013 Medium

   Linked Purβ to the DNA-damage/senescence axis by showing it binds T-oligo and is required for T-oligo-induced senescence and p53/p21/E2F1 activation.

   Evidence Biotinylated T-oligo pulldown with MS, shRNA knockdown, immunoblotting, and SA-β-gal assay in melanoma and NSCLC cells

   PMID:24379680

   Open questions at the time

   • Direct molecular role of Purβ in the senescence cascade unclear
   • Mechanism connecting T-oligo binding to p53 activation undefined
10. 2019 High

    Revealed an activating, metabolic role for Purβ by showing it directly transactivates Adcy6 to drive hepatic glucose production, with knockdown ameliorating hyperglycemia in vivo.

    Evidence ChIP, luciferase reporters, and adenoviral knockdown/overexpression in hepatocytes and db/db mice with metabolic phenotyping

    PMID:31918924

    Open questions at the time

    • Switch between repressor and activator modes unexplained
    • Cofactors at the Adcy6 promoter not identified
11. 2019 Medium

    Placed Purβ downstream of YAP/TAZ mechanosensing in Schwann cells, where it is required for myelin segment formation.

    Evidence YAP/TAZ ablation and Purβ siRNA knockdown with myelination assays in Schwann cells

    PMID:31379499

    Open questions at the time

    • Direct Purβ targets in myelination unknown
    • Whether Purβ acts transcriptionally here untested
12. 2018 Medium

    Showed Purβ can act as a transcriptional activator of mTOR and SREBP-1c, coupling amino-acid signaling to milk protein and fat synthesis.

    Evidence Knockdown/overexpression, ChIP, luciferase reporters, and PI3K inhibition in bovine mammary epithelial cells

    PMID:30362557

    Open questions at the time

    • Generality beyond mammary cells unknown
    • Determinants of activator vs repressor behavior unresolved
13. 2022 Medium

    Defined a chromatin-silencing mechanism in which Purβ partners with Cbx1 and Sp3 to position nucleosomes and recruit PRC2 for H3K27me3-mediated long-term repression of cardiomyocyte genes.

    Evidence Reciprocal Co-IP, ChIP-seq, siRNA/CRISPR editing, and in vivo reprogramming with histone modification analysis

    PMID:35605661

    Open questions at the time

    • Direct vs indirect PRC2 recruitment not fully resolved
    • Stoichiometry of the Cbx1/Sp3/Purβ complex undefined
14. 2025 High

    Established Purβ as an acetylation-dependent p53 corepressor that uses lncRNA HOTAIR to recruit EZH2 and selectively silence p21, integrating protein, DNA, and RNA recognition into one repressive mechanism.

    Evidence Biochemical purification of the p53 complex, promoter-element and acetylation-mutant epistasis, ChIP, RNA-protein interaction, and reporter assays

    PMID:40563010

    Open questions at the time

    • Structural basis of the PURB-HOTAIR interaction unknown
    • Why p21 but not PUMA/MDM2 is targeted not fully explained
15. 2025 Low

    Implicated Purβ in stress-responsive RNA compartmentalization by showing recruitment to cytoplasmic HSATIII-based RNA granules transported along microtubules.

    Evidence RNA immunoprecipitation, live-cell imaging, and granule fractionation during thermal stress recovery (preprint)

    PMID:bio_10.1101_2025.11.12.688122

    Open questions at the time

    • Preprint, not peer-reviewed
    • Functional contribution of PURB vs scaffold HSATIII RNA undetermined

• It remains unresolved what molecular switch determines whether Purβ acts as a repressor or activator at a given promoter, and whether a single structural mechanism unifies its DNA, RNA, and chromatin-silencing functions.
• No high-resolution structure of a Purβ-DNA or Purβ-RNA complex
• Activator vs repressor determinants unknown
• Genome-wide direct target catalog incomplete